We are live on ! Find out more
Allspring Global Investments

Allspring Global Investments Portfolio holdings

AUM $65.2B
1-Year Est. Return 39.42%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+39.42%
3 Year Est. Return
+106.84%
5 Year Est. Return
10 Year Est. Return
AUM
$61.3B
AUM Growth
-$2.74B
Cap. Flow
-$2.2B
Cap. Flow %
-3.59%
Top 10 Hldgs %
14.45%
Holding
2,566
New
269
Increased
893
Reduced
1,095
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Industrials 14.2%
3 Financials 11.99%
4 Consumer Discretionary 10.18%
5 Healthcare 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MQ icon
1651
Marqeta
MQ
$1.71B
$260K ﹤0.01%
11,861
+55
+0.5% +$1.21K
NWE icon
1652
NorthWestern Energy
NWE
$4.4B
$260K ﹤0.01%
5,184
-2,013
-28% -$102K
TPG icon
1653
TPG
TPG
$8.86B
$257K ﹤0.01%
6,210
+5,895
+1,871% +$252K
BAND
1654
Bandwidth Inc
BAND
$1.74B
$257K ﹤0.01%
15,208
-5,611
-27% -$106K
IJK icon
1655
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
$257K ﹤0.01%
2,913
+1,405
+93% +$124K
EVTC icon
1656
Evertec
EVTC
$1.91B
$257K ﹤0.01%
7,717
-5,068
-40% -$183K
BBVA icon
1657
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$253K ﹤0.01%
25,224
+14,018
+125% +$150K
IIPR icon
1658
Innovative Industrial Properties
IIPR
$1.67B
$253K ﹤0.01%
+2,314
New +$243K
DLB icon
1659
Dolby
DLB
$5.84B
$253K ﹤0.01%
3,189
-10,749
-77% -$865K
INTA icon
1660
Intapp
INTA
$3.16B
$252K ﹤0.01%
6,882
-4,497
-40% -$153K
RLAY icon
1661
Relay Therapeutics
RLAY
$4.37B
$252K ﹤0.01%
38,656
+29,087
+304% +$199K
SEIC icon
1662
SEI Investments
SEIC
$12.8B
$249K ﹤0.01%
3,855
-8,945
-70% -$601K
MD icon
1663
Pediatrix Medical
MD
$2.14B
$249K ﹤0.01%
33,025
-2,481
-7% -$20.5K
ACT icon
1664
Enact Holdings
ACT
$6.84B
$249K ﹤0.01%
8,117
-430
-5% -$13.1K
IAE
1665
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$94.1M
$247K ﹤0.01%
38,965
TDOC icon
1666
Teladoc Health
TDOC
$1.26B
$247K ﹤0.01%
25,250
+4,682
+23% +$57.1K
DOCU
1667
DocuSign
DOCU
$12.2B
$246K ﹤0.01%
4,606
-512
-10% -$28.9K
ARMK icon
1668
Aramark
ARMK
$16.1B
$246K ﹤0.01%
7,228
+3,307
+84% +$107K
BPMC
1669
DELISTED
Blueprint Medicines
BPMC
$246K ﹤0.01%
2,279
-24
-1% -$2.4K
NTLA icon
1670
Intellia Therapeutics
NTLA
$1.66B
$244K ﹤0.01%
10,887
+1,993
+22% +$47.5K
CAL icon
1671
Caleres
CAL
$461M
$243K ﹤0.01%
7,224
+7,201
+31,309% +$259K
CCSI icon
1672
Consensus Cloud Solutions
CCSI
$717M
$242K ﹤0.01%
14,102
-100,447
-88% -$1.63M
LEA icon
1673
Lear
LEA
$8.16B
$242K ﹤0.01%
2,118
+17
+0.8% +$2.18K
WINA icon
1674
Winmark
WINA
$1.26B
$240K ﹤0.01%
682
-2,260
-77% -$807K
VCYT icon
1675
Veracyte
VCYT
$3.42B
$240K ﹤0.01%
11,065
+1,740
+19% +$36.6K

Similar funds

Allspring Global Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Allspring Global Investments held 2,566 positions worth $61.3B, down 4.3% from $64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Allspring Global Investments withdrew a net $2.2B in Q2 2024, closing 190 positions and reducing 1,095 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $168M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Allspring Global Investments opened a new position in Franco-Nevada worth $19.4M.

  • Allspring Global Investments's largest Q2 2024 buy was Franco-Nevada: 2,332,483 shares worth $19.4M.
  • Allspring Global Investments added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $116M increase.
  • Allspring Global Investments's biggest Q2 2024 reduction was Carlisle Companies, cutting an estimated $171M.
  • Allspring Global Investments fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $168M.
  • Allspring Global Investments's ten largest holdings make up 14% of its $61.3B portfolio in Q2 2024.
  • Allspring Global Investments opened 269 new positions and closed 190 in Q2 2024.
  • Allspring Global Investments's portfolio value fell 4.3% quarter-over-quarter to $61.3B.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.